Procyon's breakthrough research findings to be presented at AACR meeting.

(From Chemical Business NewsBase - Press Release)

Procyon Biopharma Inc announced that its scientists and collaborators will be presenting four scientific posters reporting on the company's breakthrough research and therapeutic programmes at the 94th Annual American Association for Cancer Research Meeting, in Toronto, Canada, during 5-9 Apr 2003. The presentations include three posters related to Procyon's prostate secretory protein (PSP94) technology platform and one poster on the potential anti-angiogenic function of the anti-nucleosome antibodies (ANsA) platform technology based lead therapeutic monoclonal antibody. Procyon's collaborators from McGill University …